Correlation Between Corvus Pharmaceuticals and Oramed Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Oramed Pharmaceuticals.

Diversification Opportunities for Corvus Pharmaceuticals and Oramed Pharmaceuticals

CorvusOramedDiversified AwayCorvusOramedDiversified Away100%
0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Corvus and Oramed is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Oramed Pharmaceuticals go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Oramed Pharmaceuticals

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to under-perform the Oramed Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Corvus Pharmaceuticals is 1.67 times less risky than Oramed Pharmaceuticals. The stock trades about -0.36 of its potential returns per unit of risk. The Oramed Pharmaceuticals is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  227.00  in Oramed Pharmaceuticals on November 25, 2024 and sell it today you would lose (12.00) from holding Oramed Pharmaceuticals or give up 5.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Oramed Pharmaceuticals

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -40-30-20-10010
JavaScript chart by amCharts 3.21.15CRVS ORMP
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Corvus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb456789
Oramed Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Oramed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Oramed Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb2.22.42.62.83

Corvus Pharmaceuticals and Oramed Pharmaceuticals Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-10.44-7.82-5.2-2.58-0.04372.24.496.779.0511.33 0.0100.0150.0200.0250.0300.035
JavaScript chart by amCharts 3.21.15CRVS ORMP
       Returns  

Pair Trading with Corvus Pharmaceuticals and Oramed Pharmaceuticals

The main advantage of trading using opposite Corvus Pharmaceuticals and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.
The idea behind Corvus Pharmaceuticals and Oramed Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities